Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Beliefs About Medicines in Patients with Psoriasis Treated with Methotrexate or Biologics: A Cross-sectional Survey Study.

Otero ME, van den Reek JMPA, van de Kerkhof PCM, Mertens JS, Seyger MMB, Kievit W, de Jong EMGJ.

Acta Derm Venereol. 2018 Dec 13. doi: 10.2340/00015555-3108. [Epub ahead of print]

2.

Tight controlled dose reduction of biologics in psoriasis patients with low disease activity: a randomized pragmatic non-inferiority trial.

Atalay S, van den Reek JMPA, van Vugt LJ, Otero ME, van de Kerkhof PCM, den Broeder AA, Kievit W, de Jong EMGJ.

BMC Dermatol. 2017 May 8;17(1):6. doi: 10.1186/s12895-017-0057-6.

3.

Procollagen-3 N-terminal peptide measurements for the detection of liver fibrosis in methotrexate-treated patients with psoriasis: daily practice use and clinical implications.

van den Reek JMPA, Menting SP, Janssen WWL, Dhaliwal R, Heijboer AC, van Herwaarden AE, Sweep FCGJ, de Jong LM, Tjwa ET, Otero ME, Spuls PI, de Jong EMGJ.

Br J Dermatol. 2017 Nov;177(5):1454-1457. doi: 10.1111/bjd.15313. Epub 2017 Sep 10. No abstract available.

PMID:
28112796
4.

Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX-CAPTURE.

Otero ME, van den Reek JM, Seyger MM, van de Kerkhof PC, Kievit W, de Jong EM.

Br J Dermatol. 2017 Aug;177(2):497-504. doi: 10.1111/bjd.15305. Epub 2017 May 11.

PMID:
28078672
5.

Gram-positive anaerobe cocci are underrepresented in the microbiome of filaggrin-deficient human skin.

Zeeuwen PL, Ederveen TH, van der Krieken DA, Niehues H, Boekhorst J, Kezic S, Hanssen DA, Otero ME, van Vlijmen-Willems IM, Rodijk-Olthuis D, Falcone D, van den Bogaard EH, Kamsteeg M, de Koning HD, Zeeuwen-Franssen ME, van Steensel MA, Kleerebezem M, Timmerman HM, van Hijum SA, Schalkwijk J.

J Allergy Clin Immunol. 2017 Apr;139(4):1368-1371. doi: 10.1016/j.jaci.2016.09.017. Epub 2016 Oct 8. No abstract available.

6.

Validation of the Simplified Psoriasis Index in Dutch children and adolescents with plaque psoriasis.

van Geel MJ, Otero ME, de Jong EM, van de Kerkhof PC, Seyger MM.

Br J Dermatol. 2017 Mar;176(3):771-776. doi: 10.1111/bjd.15120. Epub 2016 Dec 8.

PMID:
27718521
7.

Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry.

Zweegers J, Groenewoud JMM, van den Reek JMPA, Otero ME, van de Kerkhof PCM, Driessen RJB, van Lümig PPM, Njoo MD, Ossenkoppele PM, Mommers JM, Koetsier MIA, Arnold WP, Andriessen MPM, Kuijpers ALA, Berends MAM, Kievit W, de Jong EMGJ.

Br J Dermatol. 2017 Apr;176(4):1001-1009. doi: 10.1111/bjd.15023. Epub 2017 Mar 10.

PMID:
27579864
8.

Tailored Therapist-Guided Internet-Based Cognitive Behavioral Treatment for Psoriasis: A Randomized Controlled Trial.

van Beugen S, Ferwerda M, Spillekom-van Koulil S, Smit JV, Zeeuwen-Franssen ME, Kroft EB, de Jong EM, Otero ME, Donders AR, van de Kerkhof PC, van Middendorp H, Evers AW.

Psychother Psychosom. 2016;85(5):297-307. doi: 10.1159/000447267. Epub 2016 Aug 11.

9.

Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort.

Zweegers J, Roosenboom B, van de Kerkhof PC, van den Reek JM, Otero ME, Atalay S, Kuijpers AL, Koetsier MI, Arnold WP, Berends MA, Weppner-Parren L, Bijen M, Njoo MD, Mommers JM, van Lümig PP, Driessen RJ, Kievit W, de Jong EM.

Br J Dermatol. 2017 Mar;176(3):786-793. doi: 10.1111/bjd.14888. Epub 2016 Oct 7.

PMID:
27454758
10.

Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry.

Zweegers J, van den Reek JM, van de Kerkhof PC, Otero ME, Kuijpers AL, Koetsier MI, Arnold WP, Berends MA, Weppner-Parren L, Ossenkoppele PM, Njoo MD, Mommers JM, van Lümig PP, Driessen RJ, Kievit W, de Jong EM.

Br J Dermatol. 2016 Aug;175(2):340-7. doi: 10.1111/bjd.14552. Epub 2016 Jun 25.

PMID:
26989852
11.

Effectiveness of Biologic and Conventional Systemic Therapies in Adults with Chronic Plaque Psoriasis in Daily Practice: A Systematic Review.

Zweegers J, Otero ME, van den Reek JM, van Lümig PP, Driessen RJ, Kievit W, Seyger MM, van de Kerkhof PC, de Jong EM.

Acta Derm Venereol. 2016 May;96(4):453-8. doi: 10.2340/00015555-2276. Review.

12.

A pilot study on the Psoriasis Area and Severity Index (PASI) for small areas: Presentation and implications of the Low PASI score.

Otero ME, van Geel MJ, Hendriks JC, van de Kerkhof PC, Seyger MM, de Jong EM.

J Dermatolog Treat. 2015;26(4):314-7. doi: 10.3109/09546634.2014.972316. Epub 2014 Oct 29.

PMID:
25275934
13.

Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: BioCAPTURE.

Zweegers J, van den Reek JM, van de Kerkhof PC, Otero ME, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, Kievit W, de Jong EM.

Br J Dermatol. 2014 Nov;171(5):1091-8. doi: 10.1111/bjd.13137. Epub 2014 Oct 20.

PMID:
24861358
14.

'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network.

van den Reek JM, Zweegers J, Kievit W, Otero ME, van Lümig PP, Driessen RJ, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, van de Kerkhof PC, Seyger MM, de Jong EM.

Br J Dermatol. 2014 Nov;171(5):1189-96. doi: 10.1111/bjd.13087. Epub 2014 Oct 3.

PMID:
24807471
15.

Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network.

van den Reek JM, van Lüumig PP, Otero ME, Zweegers J, van de Kerkhof PC, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, Seyger MM, Kievit W, de Jong EM.

Br J Dermatol. 2014 May;170(5):1158-65. doi: 10.1111/bjd.12862. Erratum in: Br J Dermatol. 2014 Jun;170(6):1382.

PMID:
24484403
16.

Development and design of a multidisciplinary training program for outpatient children and adolescents with psoriasis and their parents.

Oostveen AM, Spillekom-van Koulil S, Otero ME, Klompmaker W, Evers AW, Seyger MM.

J Dermatolog Treat. 2013 Feb;24(1):60-3. doi: 10.3109/09546634.2012.672707. Epub 2012 Apr 12.

PMID:
22390570
17.

Efficacy of blue light vs. red light in the treatment of psoriasis: a double-blind, randomized comparative study.

Kleinpenning MM, Otero ME, van Erp PE, Gerritsen MJ, van de Kerkhof PC.

J Eur Acad Dermatol Venereol. 2012 Feb;26(2):219-25. doi: 10.1111/j.1468-3083.2011.04039.x. Epub 2011 Mar 24.

PMID:
21435024
18.

Treatment of plaque psoriasis with the two-compound product calcipotriol/betamethasone dipropionate versus both monotherapies: an immunohistochemical study.

van der Velden HM, Pasch MC, van Erp PE, van Lingen RG, Otero ME, de Boer-van Huizen RT, van de Kerkhof PC.

J Dermatolog Treat. 2010 Jan;21(1):13-22. doi: 10.3109/09546630903214175.

PMID:
20055694
19.

Professionals' shared competences in multidisciplinary dementia care: validation of a self-appraisal instrument.

Otero ME, Drasković I, Bottema B, van Achterberg T, Lucassen PL, Degen S, Olde Rikkert MG, Vernooij-Dassen MJ.

J Am Geriatr Soc. 2009 Sep;57(9):1719-21. doi: 10.1111/j.1532-5415.2009.02427.x. No abstract available. Erratum in: J Am Geriatr Soc. 2010 Jan;58(1):215. van Achterberg, Theo [added].

PMID:
19895441
20.

Effectiveness of a multidisciplinary itch-coping training programme in adults with atopic dermatitis.

Evers AW, Duller P, de Jong EM, Otero ME, Verhaak CM, van der Valk PG, van de Kerkhof PC, Kraaimaat FW.

Acta Derm Venereol. 2009;89(1):57-63. doi: 10.2340/00015555-0556.

Supplemental Content

Loading ...
Support Center